Aurora Cannabis (NASDAQ:ACB) Releases Earnings Results, Beats Estimates By $0.15 EPS

Aurora Cannabis (NASDAQ:ACB) posted its quarterly earnings results on Wednesday. The company reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.09) by $0.15, Zacks reports. Aurora Cannabis had a negative net margin of 17.47% and a negative return on equity of 2.19%.

Aurora Cannabis Price Performance

Shares of ACB stock opened at $6.25 on Friday. The stock’s 50-day moving average is $4.24 and its two-hundred day moving average is $5.16. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a fifty-two week low of $2.84 and a fifty-two week high of $9.35.

Analysts Set New Price Targets

A number of analysts have commented on ACB shares. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. Atb Cap Markets upgraded Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Wednesday. Finally, TD Cowen assumed coverage on Aurora Cannabis in a research note on Wednesday, December 11th. They set a “buy” rating for the company.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.